Application 080388
- Type
- ANDA
- Sponsor
- ABBOTT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEPERIDINE HYDROCHLORIDE | MEPERIDINE HYDROCHLORIDE | INJECTABLE;INJECTION | 25MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A080388-001 | MEPERIDINE HYDROCHLORIDE | MEPERIDINE HYDROCHLORIDE | 25MG/ML | INJECTABLE / INJECTION | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A080388-001 | MEPERIDINE HYDROCHLORIDE | 25MG/ML | INJECTABLE / INJECTION | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A080388-001 | MEPERIDINE HYDROCHLORIDE | 25MG/ML | INJECTABLE / INJECTION | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A080388-001 | MEPERIDINE HYDROCHLORIDE | 25MG/ML | INJECTABLE / INJECTION | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEMEROL | MEPERIDINE HYDROCHLORIDE | Hospira, Inc. | b31d1308-28c3-43f4-e0a6-2f3ed76b8975 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | MEPERIDINE HYDROCHLORIDE |
| Meperidine Hydrochloride | MEPERIDINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 15bc51a8-1e24-4d33-9a2f-05a41c29acf0 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | Meperidine Hydrochloride MEPERIDINE HYDROCHLORIDE |
| Meperidine Hydrochloride | MEPERIDINE HYDROCHLORIDE | Genus Lifesciences Inc. | 792fefda-6cc4-4709-b902-fd9787fc310a | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | Meperidine Hydrochloride MEPERIDINE HYDROCHLORIDE |
| Meperidine Hydrochloride | MEPERIDINE HYDROCHLORIDE | EPIC PHARMA, LLC | fae5cc34-5917-4445-9516-25f97ffca8db | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | Meperidine Hydrochloride MEPERIDINE HYDROCHLORIDE |
| MEPERIDINE HYDROCHLORIDE | MEPERIDINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e0e998da-f056-4fce-be8e-ed60cf3b461b | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.